PABPC4 and breast carcinoma: Furthermore, in agreement with PDLIM5 being a functional effector downstream of the HNRNPC–PABPC4 axis, PDLIM5 expression was also associated with survival of patients with breast cancer (Fig. 6h and Extended Data Fig. 6i,j).